Valuation (81%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 2.11 | 28.89 |
| PEG Ratio (TTM) | 0.90 | 12.28 |
| P/S Ratio (TTM) | 6.20 | 11.93 |
| P/B Ratio (TTM) | 0.41 | 24.42 |
| P/FCF Ratio (TTM) | N/A | 25.36 |
| Price to 5YR AVG Earnings Ratio | 0.90 | 36.69 |
| Price to 5YR AVG FCF Ratio | 10.65 | 31.30 |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.56% | 15.19% |
| ROE (TTM) | 20.97% | 69.90% |
| Net Profit Margin (TTM) | 49.17% | 36.16% |
| ROIC 5YR AVG | 11.06% | 45.51% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.86% | -39.13% | -11.25% |
| Revenue | 23.57% | 804.21% | 487.40% |
| Net Income | 12.87% | -39.01% | -14.50% |
| Cash Flow | N/A | 3,689.96% | 2,238.80% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 2.29 |
| Quick Ratio (TTM) | N/A | 2.29 |
| D/E Ratio (TTM) | 0.06 | 1.60 |
| Interest Coverage (TTM) | -0.39 | 21.14 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 1.90 | 6.34 |
| LTL to 5YR AVG FCF | 0.06 | 3.48 |
| Shares Outstanding Growth 5YR AVG | -0.74% | 57.26% |